XML 35 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
OPERATING ACTIVITIES      
Net income (loss) $ 46 $ (38) $ 148
Adjustments to determine net cash provided by operating activities:      
Depreciation and amortization 360 353 352
(Gain) loss on unrealized derivatives and other realized derivatives in investing activities, net (15) (27) 39
Gain on assets held for sale (2) 0 (22)
Loss on sale of business 27 0 0
Loss on sale of assets 6 4 5
Impairment charges 2 25 7
Loss on extinguishment of debt 134 13 0
Deferred income taxes 4 (93) (88)
Amortization of fair value adjustments, net 7 11 10
Equity in net loss of non-consolidated affiliates 8 3 5
Loss (gain) on foreign exchange remeasurement of debt 2 (2) (5)
Amortization of debt issuance costs and carrying value adjustments 22 19 25
Other, net 3 0 1
Changes in assets and liabilities including assets and liabilities held for sale (net of effects from divestitures):      
Accounts receivable (154) 336 (54)
Inventories (193) 268 (390)
Accounts payable 253 (327) 578
Other current assets 9 (12) (27)
Other current liabilities 10 7 66
Other noncurrent assets (30) 20 7
Other noncurrent liabilities 76 (19) (53)
Net cash provided by operating activities 575 541 604
INVESTING ACTIVITIES      
Capital expenditures (224) (370) (518)
Proceeds from sales of assets, third party, net of transaction fees and hedging 4 3 117
Outflows from the sale of business, net of transaction fees (2) 0 0
Proceeds (outflows) from investment in and advances to non-consolidated affiliates, net 2 (2) (20)
Proceeds (outflows) from settlement of other undesignated derivative instruments, net 8 (9) 5
Net cash used in investing activities (212) (378) (416)
FINANCING ACTIVITIES      
Proceeds from issuance of long-term and short-term borrowings 4,572 174 362
Principal payments of long-term and short-term borrowings (4,477) (216) (324)
Revolving credit facilities and other, net (229) (187) 160
Return of capital to our common shareholder 0 0 (250)
Dividends, noncontrolling interest 0 (1) (1)
Debt issuance costs (191) (15) (3)
Net cash used in financing activities (325) (245) (56)
Net increase (decrease) in cash and cash equivalents 38 (82) 132
Effect of exchange rate changes on cash 0 10 (13)
Cash and cash equivalents — beginning of period 556 628 509
Cash and cash equivalents — end of period $ 594 $ 556 $ 628